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Goblet cell carcinoid, also recognized as crypt cell carcinoma and
neuroendocrine lesion with goblet cell differentiation, is a rare
gastro-intestinal malignancy that comprises both neuroendocrine
and carcinoma components (Hristov et al., 2007). This enigmatic,
intra-abdominal neoplasm is clinically deﬁned by the presence of
mucin within the peritoneal cavity (Young, 2004); in particular,
immunohistochemistry staining demonstrates that MUC2 is a highly
speciﬁc marker of goblet cell metaplasia (Basham et al., 2000).
Studies have attempted to categorize goblet cell carcinoid with the
intent to anticipate a patient's clinical course and prognosis (Chetty et
al., 2010); three histologic subtypes have since been delineated: the
typical goblet cell carcinoid, adenocarcinoma ex goblet cell carcinoid
with signet ring cell type, and adenocarcinoma ex goblet cell carcinoid
with poorly differentiated carcinoma type. Nevertheless, the biologic
behavior of goblet cell carcinoid is indeterminate and thus remains
complicated.
Goblet cell carcinoid can be confounding insofar as determining
whether they are independent lesions or a metastasis (Hristov et al.,
2007). Moreover, since the incidental detection of this disease within
the gynecologic tract is so rare, timely, clinical management may be
discomﬁted (Basham et al., 2000;Moore et al., 1998).We describe herein
a very rare case involving a patient diagnosed and treated for an intrae-
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An 80 year-old (gravida 5, para 5) Caucasian woman was referred
to our clinic with a large pelvic mass in January 2011; she had both an
elevated CA-125 of 152 U/ml and a CA15-3 of 173 U/ml. A CT scan of
the abdomen and pelvis revealed a 51×30 mm right adnexal mass
(Fig. 1). The patient was subsequently admitted for deﬁnitive surgical
management. Her medical history was signiﬁcant for recurrent breast
cancer, thyroid cancer and cholelithiasis.
Initially, a diagnostic laparoscopy involving the abdomen and
pelvis was conducted to preclude extensive disease involvement.
Thereafter, a right-sided salpingo-oophorectomy was performed;
the right ovary was removed and submitted for frozen section. The
patient tolerated the procedure well and was taken to the recovery
room, with no immediate postoperative complications.
Gross sectioning revealed a 4.8×0.8 cm fallopian tube with distinct
ﬁmbria and a disrupted ovary, measuring 3.0×2.5 cm; this was initially
presumed to be benign serous cystadenoma (Figs. 2a–e). Therewas also
a 1.5 cmdisrupted cystic structure, exhibiting a ﬁnely nodular, papillary
excrescence. Frozen section diagnosis was consistent with benign
serous cyst and focal epithelial crowding.
Microscopically, the ovary and cysts demonstrated ﬁbrotic stroma
interrupted by serous epithelium. In the fallopian tube, there were
small foci of moderate to marked atypia and goblet cell metaplasia,
consistent withmucinous proliferation. Immuno-histochemical stains
were positive for mucin, CEA and Ki-67, suggestive of intraepithelial
carcinoma; conversely, they were negative for WT-1 and p53, which
precluded a serous carcinoma. Final pathologic diagnosis revealed
intraepithelial carcinoma with mucinous, goblet cell differentiation.
The disease potentially originated from a tubal primary, extending
from a cervical adenocarcinoma or non-gynecological source.
In February 2011, the patient underwent an endocervical curettage
and endometrial biopsy, both of which were negative for dysplasia or
malignancy. Since the patient has a history of breast cancer, she was
referred to genetic counseling for an assessment of her BRCA status;
the results of her BRCA test were negative. The patient has remained
disease free and is doing well with 10 months of follow-up.Discussion
Goblet cells have been identiﬁed within the normal and metaplastic
cervical or vaginal epithelium although they are more frequently
encountered in the intestinal tract (Hristov et al., 2007). However,
Fig. 1. CT scan of the abdomen and pelvis demonstrating a 51×30 mm septated, cystic mass within the right adnexa, presumably arising from the right ovary.
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which the vagina and cervix are comprised, the presence of goblet
cells in these aforementioned gynecologic locations is not entirely
unexpected (McLean, 2003); reported studies have described the
presence of goblet cell metaplasia within the endometrial cavity and
ovaries (Fox et al., 1988; Wells and Tiltman, 1989).
In the current evaluation, we describe an unusual case involving a
patient who presented with an extensive pelvic lesion. Following
surgery, the disease was presumed to be a benign serous cystade-
noma; ﬁnal pathologic evaluation revealed intraepithelial carcinoma
with mucinous, goblet cell differentiation, presumably originating
from primary fallopian tube cancer. Since the disease was apparently
conﬁned and there was not a signiﬁcant concern that this represented
a metastatic process, neither a lymphadenectomy nor an evaluation
of the gastro-intestinal tract was conducted.
The case study is extremely noteworthy in that the lesion was
intraepithelial and thus exhibits the differentiating capacity of the
fallopian tube epithelium, particularly in women who have a positive
BRCA proﬁle (Lee et al., 2007). Following consideration of the
relationship between primary tubal cancer and BRCA status, the
patient was referred for genetic counseling. Additionally, albeit
unlikely, one could conjecture that the disease arose from cervical
adenocarcinoma or a non-gynecologic source.
Moore et al. (1998) described two patients with neoplasms
comprising well differentiated goblet cell epithelium within theendometrium and cervix. In both cases, cytokeratin staining was
employed to differentiate between an ovarian mucinous or gastrointes-
tinal mucinous lesion. Surgical management for these two patients was
more invasive (i.e., a hysterectomy was performed) than in the current
study because their diseasewas associatedwith eithermultiple implants
or peritoneal dissemination.
Basham et al. described the clinical course of a gravid patient
treated for an adenocarcinoid tumor of the ovary, which contained
mucinous and goblet cells (Basham et al., 2000). Initially, the affected
ovary and fallopian tube were removed for pathologic evaluation;
after the 20th week, the contralateral ovary and fallopian tube
were resected and the gastrointestinal tract was scrutinized to
preclude the possibility of a coincident malignant process. The patient
recovered postoperatively and had a successful delivery.
When goblet cell carcinoid is detected within the endometrium via
endometrial or cervical biopsy, the condition may be indicative of
metaplasia, ovarian involvement or extra-uterine inﬁltration via the
fallopian tube lumen (Moore et al., 1998). Thus, it is paramount to
determine fromwhere the lesion arises (Hristov et al., 2007); immuno-
histochemical (e.g., cytokeratin and carcinoembryonic antigen (CEA))
staining and genetic testing have had moderate success distinguishing
between mucinous tumors originating from either the gastrointestinal
tract or the ovary (Hristov et al., 2007; Chetty et al., 2010; Chuaqui et
al., 1996). In the current study, immunohistochemical staining was
positive for CEA and mucin; Ki-67 staining was high in atypical areas.
Fig. 2. a. Tubal mucosa with mucinous differentiation and goblet cells (10×). b. High power showing atypia andmitotic activity. c. Complex architecture (cribriforming) of mucinous
epithelium. d. Mucin stain highlighting goblet cells with intracellular mucin. e. Ki-67 showing high proliferative activity.
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should comprise surgery and extended follow-up (Moore et al., 1998).
Moreover, since reported cases primarily involve malignant disease,
physicians should attempt to determine the lesion's provenance and if
there was evidence of dissemination, particularly to exclude metastatic
involvement (Hristov et al., 2007; Young, 2004). This further
underscores the contention that a surgeon should scrutinize the gastro-
intestinal tract when addressing ovarian cancer that is bilateral
or mucinous (Chetty et al., 2010; Moore et al., 1998). Additional
study of the pathologic and biologic characteristics of goblet cellcarcinoid should facilitate accurate diagnosis and improve clinical
management.Ethical consent
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